Peter Libby news from FiercePharma
News
Docs go cold turkey on industry pay
The shape of things to come, or a few anomalies that prove the prevailing trend? A few prominent research doctors are saying "No, thanks," to any payments from drug and device companies. Read more...
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends